HomeCompareKRMCF vs CL

KRMCF vs CL: Dividend Comparison 2026

KRMCF yields 454.55% · CL yields 2.43%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 KRMCF wins by $29619.00M in total portfolio value
10 years
KRMCF
KRMCF
● Live price
454.55%
Share price
$0.44
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$29619.04M
Annual income
$20,672,526,630.46
Full KRMCF calculator →
CL
CL
● Live price
2.43%
Share price
$85.73
Annual div
$2.08
5Y div CAGR
28.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$40.8K
Annual income
$5,401.96
Full CL calculator →

Portfolio growth — KRMCF vs CL

📍 KRMCF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodKRMCFCL
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, KRMCF + CL cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
KRMCF pays
CL pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

KRMCF
Annual income on $10K today (after 15% tax)
$38,636.36/yr
After 10yr DRIP, annual income (after tax)
$17,571,647,635.89/yr
CL
Annual income on $10K today (after 15% tax)
$206.23/yr
After 10yr DRIP, annual income (after tax)
$4,591.67/yr
At 15% tax rate, KRMCF beats the other by $17,571,643,044.23/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of KRMCF + CL for your $10,000?

KRMCF: 50%CL: 50%
100% CL50/50100% KRMCF
Portfolio after 10yr
$14809.54M
Annual income
$10,336,266,016.21/yr
Blended yield
69.79%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on CL right now

KRMCF
No analyst data
CL
Analyst Ratings
17
Buy
24
Hold
2
Sell
Consensus: Hold
Price Target
$92.45
+7.8% upside vs current
Range: $85.00 — $100.00
Altman Z
4.5
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

KRMCF buys
0
CL buys
0
No recent congressional trades found for KRMCF or CL in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricKRMCFCL
Forward yield454.55%2.43%
Annual dividend / share$2.00$2.08
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28.6%
Portfolio after 10y$29619.04M$40.8K
Annual income after 10y$20,672,526,630.46$5,401.96
Total dividends collected$28823.07M$18.0K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: KRMCF vs CL ($10,000, DRIP)

YearKRMCF PortfolioKRMCF Income/yrCL PortfolioCL Income/yrGap
1← crossover$56,155$45,454.55$11,012$312.01+$45.1KKRMCF
2$298,635$238,549.47$12,196$412.95+$286.4KKRMCF
3$1,505,172$1,185,632.86$13,599$549.66+$1.49MKRMCF
4$7,195,392$5,584,858.27$15,288$736.64+$7.18MKRMCF
5$32,650,572$24,951,502.07$17,353$995.28+$32.63MKRMCF
6$140,751,597$105,815,484.50$19,926$1,357.80+$140.73MKRMCF
7$576,916,626$426,312,417.48$23,194$1,873.82+$576.89MKRMCF
8$2,250,367,516$1,633,066,726.35$27,439$2,621.52+$2250.34MKRMCF
9$8,361,231,346$5,953,338,104.06$33,088$3,727.38+$8361.20MKRMCF
10$29,619,044,171$20,672,526,630.46$40,806$5,401.96+$29619.00MKRMCF

KRMCF vs CL: Complete Analysis 2026

KRMCFStock

KRM22 Plc, together with its subsidiaries, develops and sells risk management software to the financial services industry in the United Kingdom, Europe, the United States, and internationally. The company offers Risk Cockpit, which shows enterprise risk profile in real time; Regulatory Navigator that brings out-the-box regulatory functionality covering market abuse, SM&CR, and financial crime; and Market Surveillance that offers analytics and contextual market surveillance tools to help capital markets firms identify and manage the potential risks of market abuse, fraud, and operational breaches. It also provides Individual Accountability Regime, which allows financial institutions to manage accountability throughout the firm; Digital Client Onboarding that provides capital market firms with the tools to make client onboarding; and Regulatory Reporting that enables capital market firms to comply with its regulatory reporting obligations across multiple jurisdictions. In addition, the company offers Enhanced Due Diligence, which enables firms to understand online reputational risks and evidence compliance; Regulatory training that helps regulated firms address their mandatory training requirements; Post-Trade Risk – Stress, which scales the type and amount of risk calculations performed against various limits and risk slides; and Post-Trade Risk – VaR that provides the unique view of multiple VaR calculations across the whole portfolio in a single place. Further, it provides At-Trade Risk, which offers P&L and exchange margin for clearing houses and members, traders, brokers, and other financial institutions that make decisions based on the management of risk; and Pre-Trade Risk, which helps combat time consuming and error prone processes by maintaining pre-trade limits in one centralized application. The company was founded in 2017 and is headquartered in London, the United Kingdom.

Full KRMCF Calculator →

CLConsumer Staples

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under various brands, which include Colgate, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, Irish Spring, Palmolive, Protex, Sanex, Softsoap, Lady Speed Stick, Speed Stick, EltaMD, Filorga, PCA SKIN, Ajax, Axion, Fabuloso, Murphy, Suavitel, Soupline, and Cuddly to a range of traditional and eCommerce retailers, wholesalers, and distributors. It also includes pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic products to manage disease conditions in dogs and cats under the Hill's Prescription Diet brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.

Full CL Calculator →
📬

Get this KRMCF vs CL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

KRMCF vs SCHDKRMCF vs JEPIKRMCF vs OKRMCF vs KOKRMCF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.